Philips: FDA lifts injunction on defibrillators

(CercleFinance.com) - Philips is resuming the manufacturing and delivery of its defibrillators in the US, after the Food and Drug Administration lifted an injunction prohibiting these activities.


The Dutch health technology company was previously required to suspend manufacture and distribution of its defibrillators from specific facilities in the US, pending inspection and certification from the FDA.

In the midst of the Covid-19 crisis, Philips has managed to enhance the regulatory compliance processes in its emergency care and resuscitation (ECR) business.

Copyright (c) 2020 CercleFinance.com. All rights reserved.